Can India repeat the success of generics in US (United States) biosimilar market? an analysis of current FDA's stand on biosimilars

S. Moorkoth, Y. Gujar, D. Bukka

Research output: Contribution to journalArticle

Original languageUndefined/Unknown
Pages (from-to)27-31
Number of pages5
JournalPharma Times
Volume45
Issue number1
Publication statusPublished - 2013

Cite this